Cost a major factor for missed genetic testing during pregnancy With no Medicare rebate, financial barriers are preventing many pregnant people from accessing non-invasive screening for common genetic conditions.
In Practice: Calls for business viability representatives The RACGP is seeking members to help inform the development of its general practice business and financial viability work.
Breast cancer detection delayed by COVID-19 The rate of metastatic breast cancer doubled after breast screening programs shut down during the pandemic.
Age lowered for bowel cancer screening From the age of 45, eligible Australians will soon be able to screen with the national program as part of this year’s Federal Budget package.
In Practice: Further calls for feedback on Scope of Practice review The RACGP is encouraging members to share their views on the proposed policy reforms across the three key theme areas.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.
HPV self-collection: Are you ready to support the choice? SPONSORED: A new national public awareness campaign is expected to create significant patient demand for the service.
Should the breast screening age be lowered? While the question has again been put forward, Australian experts remain unconvinced, saying participation among target groups is more important.
Is general practice ready for the genetic carrier screening surge? GPs must be educated and resourced to meet the ‘inevitable widespread uptake’ of the newly Medicare-funded service, says a new study.
Self-collection reaching under-screened populations Uptake of the cervical cancer screening option has been particularly high among Aboriginal and Torres Strait Islander people in the NT.